$22M NIH award will accelerate 'CRISPR' research at UC Berkeley, Ohio State

The National Institutes of Health (NIH) is incentivizing researchers to think beyond single applications of genome editing and to develop platform approaches that can be used to address multiple diseases.

Related Keywords

Ohio ,United States ,Krystof Bankiewicz ,Niren Murthy ,Claire Clelland ,Russell Lonser ,Jerusha Naidoo ,Petros Giannikopoulos ,Victor Van Laar ,Fyodor Urnov ,Jennifer Doudna ,Ross Wilson ,Emmanuelle Charpentier ,Ohio State Department Of Neurological Surgery ,College Of Medicine ,National Institutes Of Health ,Innovative Genomics Institute ,Ohio State Gene Therapy Institute ,Ohio State University Wexner Medical Center ,National Institutes ,Cell Genome Editing ,Neurological Disease ,Allele Specific Excision ,Investigational New Drug ,Ohio State ,Ohio State Department ,Gene Therapy Institute ,